116 related articles for article (PubMed ID: 12081144)
1. Liver targeting liposomes containing beta-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells.
Kawano K; Nakamura K; Hayashi K; Nagai T; Takayama K; Maitani Y
Biol Pharm Bull; 2002 Jun; 25(6):766-70. PubMed ID: 12081144
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
[TBL] [Abstract][Full Text] [Related]
4. The enhancing effect of soybean-derived sterylglucoside and beta-sitosterol beta-D-glucoside on nasal absorption in rabbits.
Maitani Y; Nakamura K; Suenaga H; Kamata K; Takayama K; Nagai T
Int J Pharm; 2000 Apr; 200(1):17-26. PubMed ID: 10845682
[TBL] [Abstract][Full Text] [Related]
5. [Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
Shi J; Qi XR; Yang L; Fei R; Wei L
Yao Xue Xue Bao; 2006 Jan; 41(1):19-23. PubMed ID: 16683522
[TBL] [Abstract][Full Text] [Related]
6. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
[TBL] [Abstract][Full Text] [Related]
7. [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35].
Zhang Y; Qi XR; Gao Y; Wei L
Yao Xue Xue Bao; 2006 Nov; 41(11):1111-5. PubMed ID: 17262957
[TBL] [Abstract][Full Text] [Related]
8. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes.
Hwang SH; Hayashi K; Takayama K; Maitani Y
Gene Ther; 2001 Aug; 8(16):1276-80. PubMed ID: 11509962
[TBL] [Abstract][Full Text] [Related]
9. Low concentrations of primaquine inhibit degradation but not receptor-mediated endocytosis of asialoorosomucoid by HepG2 cells.
Reif JS; Schwartz AL; Fallon RJ
Exp Cell Res; 1991 Feb; 192(2):581-6. PubMed ID: 1703087
[TBL] [Abstract][Full Text] [Related]
10. Association of liposomes containing a soybean-derived sterylglucoside mixture with rat primary cultured hepatocytes.
Shimizu K; Maitani Y; Takahashi N; Takayama K; Nagai T
Biol Pharm Bull; 1998 Aug; 21(8):818-22. PubMed ID: 9743249
[TBL] [Abstract][Full Text] [Related]
11. Specific and efficient gene delivery mediated by an asialofetuin-associated nanosystem.
Farinha D; Pedroso de Lima MC; Faneca H
Int J Pharm; 2014 Oct; 473(1-2):366-74. PubMed ID: 25051113
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
13. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
Arangoa MA; Düzgüneş N; Tros de Ilarduya C
Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
[TBL] [Abstract][Full Text] [Related]
14. The enhancing effect of nasal absorption of FITC-dextran 4,400 by beta-sitosterol beta-D-glucoside in rabbits.
Nakamura K; Maitani Y; Takayama K
J Control Release; 2002 Feb; 79(1-3):147-55. PubMed ID: 11853926
[TBL] [Abstract][Full Text] [Related]
15. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
16. Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.
Ishihara H; Hayashi Y; Hara T; Aramaki Y; Tsuchiya S; Koike K
Biochem Biophys Res Commun; 1991 Jan; 174(2):839-45. PubMed ID: 1704230
[TBL] [Abstract][Full Text] [Related]
17. Regional intestinal absorption of FITC-dextran 4,400 with nanoparticles based on beta-sitosterol beta-D-glucoside in rats.
Nakamura K; Takayama K; Nagai T; Maitani Y
J Pharm Sci; 2003 Feb; 92(2):311-8. PubMed ID: 12532381
[TBL] [Abstract][Full Text] [Related]
18. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture for liver targeting.
Shimizu K; Maitani Y; Takayama K; Nagai T
J Drug Target; 1996; 4(4):245-53. PubMed ID: 9010814
[TBL] [Abstract][Full Text] [Related]
20. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor.
Mkhwanazi NK; de Koning CB; van Otterlo WAL; Ariatti M; Singh M
Z Naturforsch C J Biosci; 2017 Jul; 72(7-8):293-301. PubMed ID: 28063265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
